Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIALYTE W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIALYTE W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER vs DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intraperitoneal administration of hypertonic dextrose solution creates an osmotic gradient across the peritoneal membrane, facilitating ultrafiltration and removal of uremic toxins through peritoneal dialysis.
Removes uremic toxins, corrects electrolyte imbalances, and removes excess fluid via peritoneal dialysis.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day, or as prescribed for continuous ambulatory peritoneal dialysis (CAPD); may adjust volume and frequency based on patient's fluid and electrolyte status.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day (typical for continuous ambulatory peritoneal dialysis).
None Documented
None Documented
Dextrose terminal half-life is approximately 1-2 hours in normal metabolism; in peritoneal dialysis, continuous removal leads to variable half-life depending on dwell time and ultrafiltration; clinical context: continuous exposure during dwell.
Dextrose: ~2-2.5 hours (glucose turnover); electrolytes and lactate have rapid distribution and elimination half-lives of minutes to hours. In renal impairment, half-life of dialyzed solutes may be prolonged.
Peritoneal dialysis solution; dextrose is metabolized and eliminated via peritoneal dialysis; approximately 70-80% of dextrose is absorbed systemically and metabolized; the non-absorbed fraction is removed with dialysate outflow; lactate (buffer) is converted to bicarbonate in the liver and eliminated via respiration and urine.
Primarily renal; glucose and electrolytes are reabsorbed or excreted by kidneys. For IP administration, dialysis fluid components (e.g., dextrose, sodium, chloride, lactate) are absorbed and then eliminated via renal and metabolic pathways: ~60% of absorbed dextrose is metabolized, remainder excreted renally; electrolytes are excreted renally; lactate is metabolized to bicarbonate.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution